India
Generic drugmaker Hetero launches drug for COVID-19 patients
Generic drugmaker Hetero has received the Drug Controller General of India (DCGI) approval to manufacture and offer its generic variation of Gilead’s Remdesivir for the treatment of Covid-19 patients in the country.
The generic variation will be marketed under the brand name ‘Covifor’ in India, Hetero said about the product that is being produced at its facility